Thermo Fisher Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Thermo Fisher Scientific has a total shareholder equity of $45.6B and total debt of $35.6B, which brings its debt-to-equity ratio to 78%. Its total assets and total liabilities are $97.1B and $51.5B respectively. Thermo Fisher Scientific's EBIT is $7.4B making its interest coverage ratio 17.4. It has cash and short-term investments of $7.3B.
Key information
78.0%
Debt to equity ratio
US$35.61b
Debt
Interest coverage ratio | 17.4x |
Cash | US$7.25b |
Equity | US$45.62b |
Total liabilities | US$51.47b |
Total assets | US$97.10b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TMOF's short term assets ($23.6B) exceed its short term liabilities ($13.9B).
Long Term Liabilities: TMOF's short term assets ($23.6B) do not cover its long term liabilities ($37.5B).
Debt to Equity History and Analysis
Debt Level: TMOF's net debt to equity ratio (62.2%) is considered high.
Reducing Debt: TMOF's debt to equity ratio has increased from 65.9% to 78% over the past 5 years.
Debt Coverage: TMOF's debt is well covered by operating cash flow (25.1%).
Interest Coverage: TMOF's interest payments on its debt are well covered by EBIT (17.4x coverage).